Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma

[1]  S. Sebens,et al.  Entry and exit of chemotherapeutically-promoted cellular dormancy in glioblastoma cells is differentially affected by the chemokines CXCL12, CXCL16, and CX3CL1 , 2020, Oncogene.

[2]  S. Kreth,et al.  MicroRNA-93 acts as an “anti-inflammatory tumor suppressor” in glioblastoma , 2020, Neuro-oncology advances.

[3]  S. Kreth,et al.  The IL-1 Antagonist Anakinra Attenuates Glioblastoma Aggressiveness by Dampening Tumor-Associated Inflammation , 2020, Cancers.

[4]  A. Giordano,et al.  Autocrine CXCL8-dependent invasiveness triggers modulation of actin cytoskeletal network and cell dynamics , 2020, Aging.

[5]  Bin Wang,et al.  High gene expression levels of VEGFA and CXCL8 in the peritumoral brain zone are associated with the recurrence of glioblastoma: A bioinformatics analysis , 2019, Oncology letters.

[6]  Fuhui Long,et al.  An anatomic transcriptional atlas of human glioblastoma , 2018, Science.

[7]  Damien Y. Duveau,et al.  Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma , 2017, Nature.

[8]  Deric M. Park,et al.  Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells , 2017, Neuro-oncology.

[9]  Erwin G. Van Meir,et al.  Overcoming therapeutic resistance in glioblastoma: the way forward. , 2017, The Journal of clinical investigation.

[10]  Yaoqi Zhou,et al.  Predicting the errors of predicted local backbone angles and non-local solvent- accessibilities of proteins by deep neural networks , 2016, Bioinform..

[11]  Bing He,et al.  EnhancerAtlas: a resource for enhancer annotation and analysis in 105 human cell/tissue types , 2016, Bioinform..

[12]  Atique U. Ahmed,et al.  Dedifferentiation of Glioma Cells to Glioma Stem-like Cells By Therapeutic Stress-induced HIF Signaling in the Recurrent GBM Model , 2016, Molecular Cancer Therapeutics.

[13]  K. Helin,et al.  Maintaining cell identity: PRC2-mediated regulation of transcription and cancer , 2016, Nature Reviews Cancer.

[14]  Anping Li,et al.  The CXCL8-CXCR1/2 pathways in cancer , 2016, Cytokine & growth factor reviews.

[15]  A. Bracken,et al.  PRC2 mediated H3K27 methylations in cellular identity and cancer. , 2015, Current opinion in cell biology.

[16]  E. Biskup,et al.  Co-expression of CXCL8 and HIF-1α is associated with metastasis and poor prognosis in hepatocellular carcinoma , 2015, Oncotarget.

[17]  B. Ozpolat,et al.  Dedifferentiation of patient-derived glioblastoma multiforme cell lines results in a cancer stem cell-like state with mitogen-independent growth , 2015, Journal of cellular and molecular medicine.

[18]  C. Toulas,et al.  Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance , 2014, Cell Death and Disease.

[19]  Shawn M. Gillespie,et al.  Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.

[20]  J. Satoh,et al.  Human Astrocytes: Secretome Profiles of Cytokines and Chemokines , 2014, PloS one.

[21]  Atique U. Ahmed,et al.  Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy , 2014, Cell Death and Differentiation.

[22]  Claudia Fischbach,et al.  Glioblastoma stem cells are regulated by interleukin-8 signaling in a tumoral perivascular niche. , 2013, Cancer research.

[23]  C. Seoighe,et al.  Semi-supervised Nonnegative Matrix Factorization for gene expression deconvolution: a case study. , 2012, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[24]  H. Pilegaard,et al.  IL‐6 regulates exercise and training‐induced adaptations in subcutaneous adipose tissue in mice , 2012, Acta physiologica.

[25]  Lothar Hennighausen,et al.  EZH2 Methyltransferase and H3K27 Methylation in Breast Cancer , 2011, International journal of biological sciences.

[26]  Max S Wicha,et al.  Breast cancer stem cells, cytokine networks, and the tumor microenvironment. , 2011, The Journal of clinical investigation.

[27]  H. Kettenmann,et al.  The brain tumor microenvironment , 2011, Glia.

[28]  R. McLendon,et al.  Acidic stress promotes a glioma stem cell phenotype , 2011, Cell Death and Differentiation.

[29]  P. L. Puri,et al.  Phosphoryl-EZH-ion. , 2011, Cell stem cell.

[30]  G. Dontu,et al.  Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. , 2011, Cancer research.

[31]  D. Reinberg,et al.  Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA. , 2010, Genes & development.

[32]  M. Jovanović,et al.  Interleukin-8 (CXCL8) stimulates trophoblast cell migration and invasion by increasing levels of matrix metalloproteinase (MMP)2 and MMP9 and integrins alpha5 and beta1. , 2010, Reproduction.

[33]  S. Lakhan,et al.  Inflammatory mechanisms in ischemic stroke: therapeutic approaches , 2009, Journal of Translational Medicine.

[34]  J. Sarkaria,et al.  Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft model , 2009, Journal of Neuro-Oncology.

[35]  S. Guha,et al.  CXCL8/IL‐8 and CXCL12/SDF‐1α co‐operatively promote invasiveness and angiogenesis in pancreatic cancer , 2009 .

[36]  G. Reifenberger,et al.  Temozolomide preferentially depletes cancer stem cells in glioblastoma. , 2008, Cancer research.

[37]  Y. Lee,et al.  Role of hypoxia-inducible factor-1alpha in hypoxia-induced expressions of IL-8, MMP-1 and MMP-3 in rheumatoid fibroblast-like synoviocytes. , 2008, Rheumatology.

[38]  D. Trisciuoglio,et al.  Modulation of bcl-xL in Tumor Cells Regulates Angiogenesis through CXCL8 Expression , 2007, Molecular Cancer Research.

[39]  A. Fisher,et al.  Epigenetic signatures of stem-cell identity , 2007, Nature Reviews Genetics.

[40]  V. Kalra,et al.  A Novel Role of Hypoxia-Inducible Factor in Cobalt Chloride- and Hypoxia-Mediated Expression of IL-8 Chemokine in Human Endothelial Cells12 , 2006, The Journal of Immunology.

[41]  Kristian Helin,et al.  Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. , 2006, Genes & development.

[42]  Manish Gala,et al.  Induction of interleukin-8 preserves the angiogenic response in HIF-1α–deficient colon cancer cells , 2005, Nature Medicine.

[43]  Stanley Nattel,et al.  Atrial Tachycardia Remodeling of Pulmonary Vein Cardiomyocytes: Comparison With Left Atrium and Potential Relation to Arrhythmogenesis , 2005, Circulation.

[44]  R. Stupp,et al.  Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Temozolomide in Malignant Glioma Patients , 2004, Clinical Cancer Research.

[45]  P. Beale,et al.  Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies , 1999, British Journal of Cancer.

[46]  A. Sudarikov,et al.  Differential action of cycloheximide and activation stimuli on transcription of tumor necrosis factor-alpha, IL-1 beta, IL-8, and P53 genes in human monocytes. , 1993, Journal of immunology.

[47]  X. Ren,et al.  IL-8, a novel messenger to cross-link inflammation and tumor EMT via autocrine and paracrine pathways (Review). , 2016, International journal of oncology.

[48]  F. Turkheimer,et al.  A new model for prediction of drug distribution in tumor and normal tissues: pharmacokinetics of temozolomide in glioma patients. , 2009, Cancer research.